Steady Expansion Forecast for Peptic Ulcer Market, Projected to Reach $4.91 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Peptic Ulcer Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the peptic ulcer market has been demonstrating consistent growth. It is projected to expand from $4.1 billion in 2024 to $4.24 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.5%. The growth observed in the historical period can be linked to the increased incidence of helicobacter pylori infection, the escalating usage of nonsteroidal anti-inflammatory drugs (NSAIDs), alterations in lifestyles and eating habits, awareness drives and educational programs, as well as a concentration on stress management.

Peptic Ulcer Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size of peptic ulcers is predicted to experience consistent growth. It is forecasted to increase to $4.91 billion by 2029 at a compound annual growth rate of 3.7%. The predicted growth during the forecast period can be tied to the rise of new therapies and treatment modalities, an expanding elderly population, the incorporation of precision medicine, health promotion and preventive steps, as well as ongoing research and clinical trials. The forecast period will also see major trends such as incorporation of digital health solutions, improvement in treatment methodologies, a higher prevalence of Helicobacter pylori infection, integration of diagnostic imaging technologies, and a surge in the use of combination therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

What Are the Drivers Transforming the Peptic Ulcer Market?
The rise in obesity rates is likely to boost the progress of the peptic ulcer market. Obesity is defined as an excessive increase in body fat, which typically results in a Body Mass Index (BMI) of 30 or higher. This health condition can be caused by genetic, environmental, and lifestyle factors like an unhealthy diet and insufficient physical activity. Obesity causes an overproduction of stomach acid, weakens the protective lining of the stomach, and aids the formation of peptic ulcers. It also seems excess body weight can stimulate inflammation in the gut, contributing to the emergence of peptic ulcers. For example, the Centers for Disease Control and Prevention stated in September 2024 that between August 2021 and August 2023, adult obesity prevalence stood at 40.3%, with men accounting for 39.2% and women at 41.3%. As such, the increasing occurrence of obesity is stimulating the peptic ulcer market's growth. In relation to the peptic ulcer market, another contributing factor is the escalation in smoking rates which is projected to thrust the market's development in the upcoming future. Smoking, which involves inhalation and exhalation of fumes from burning plant-based substances like tobacco or marijuana, is an established cause of peptic ulcer disease. It heightens the occurrence of peptic ulcers by damaging the protective linings of the stomach and duodenum, reducing the stomach's blood supply and increasing the production of stomach acid. To put into perspective, Quit Victoria, a program by Australia's Cancer Council Victoria supported by Cancer Council Victoria, VicHealth, the Victorian Department of Health, and the Australian Government's alcohol, tobacco, and other drugs branch, noted in June 2023 that between 14-17 year olds, current cigarette smoking rates had tripled in four years, reaching 6.7% in 2022. Therefore, the rising smoking rates are contributing to the peptic ulcer market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

What Long-Term Trends Will Define the Future of the Peptic Ulcer Market?
In the competitive peptic ulcer market, businesses are focusing on groundbreaking product innovation and tackling federal approval processes. Developing new drugs is a fundamental strategy for the control and treatment of peptic ulcers. These medications aid in handling symptoms, promoting healing, preventing complications, and addressing the root issue. For example, Akums Drugs and Pharmaceutical Ltd., a firm based in India known for its pharmaceutical formulations and APIs, unveiled its new Combikit in April 2023. This preparation encapsulates Amoxicillin, Clarithromycin, and Esomeprazole. The Combikit has been sanctioned by the Central Drugs Standard Control Organisation (CDSCO) for the management of duodenal ulcers related to H. pylori and the elimination of this microorganism in patients with active or recovered peptic ulcers. Treatments designed to diminish H. pylori have shown efficacy in mitigating the potential for ulcer recurrence, thus providing significant patient benefits. H. pylori infections are common in India and are known to contribute to gastritis and peptic ulcer developments.

Which Segments in the Peptic Ulcer Market Offer the Most Profit Potential?
The peptic ulcer market covered in this report is segmented -

1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce

Subsegments:
1) By Gastritis: Acute Gastritis, Chronic Gastritis
2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer
3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13221&type=smp

Which Firms Dominate the Peptic Ulcer Market by Market Share and Revenue in 2025?
Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Which Regions Offer the Highest Growth Potential in the Peptic Ulcer Market?
North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13221

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.